Malaria vaccine wows and seeds COVID-19 vaccine effort
Published in Nature Biotechnology
A malaria vaccine not only has achieved record-setting protection in a large trial, but also spurred the UK’s COVID-19 vaccine effort.
Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseases
Published in Nature Biotechnology
A survey of patenting activity can facilitate coordination of R&D activities to fight emerging infectious diseases.
China at the threshold
Published in Nature Biotechnology
China’s growing influence in biotech was underscored in 2020 during a record-breaking year for sector financing.
Regulatory and intellectual property conundrums surrounding xenotransplantation
Published in Nature Biotechnology
Publisher Correction: ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics
Published in Nature Biotechnology
‘Super-antibodies’ could curb COVID-19 and help avert future pandemics
Published in Nature Biotechnology
Companies are designing next-generation antibodies modeled on those taken from unique individuals whose immune systems can neutralize any COVID-19 variant—and related coronaviruses, too.
Publisher Correction: Questions swirl around failures of disease-modifying Huntington’s drugs
Published in Nature Biotechnology
Voices of biotech leaders
...Published in Nature Biotechnology
Nature Biotechnology asks a selection of leaders from across biotech to look at the future of the sector and make some predictions for the coming years.
Questions swirl around failures of disease-modifying Huntington’s drugs
Published in Nature Biotechnology
Researchers hope that antisense oligo clinical trial failures in Huntington’s will shed light on mechanism and drug biodistribution and galvanize ongoing drug development efforts.
When mentoring matters: a French mentoring program for women in science
Published in Nature Biotechnology
An innovative program addresses the need for support, encouragement and guidance on the part of women scientists in the early years of their career, during their PhD.
